Reproductive potential

Drug	Drug Name	Drug Description
DB17083	Linzagolix	A selective gonadotropin-releasing hormone (GnRH) receptor antagonist used for the symptomatic treatment of uterine fibroids.
DB13055	Oteseconazole	An azole antifungal used to prevent recurrent vulvovaginal candidiasis in females who are not of reproductive potential.

Drug	Drug Name	Target	Type
DB17083	Linzagolix	Cytochrome P450 2C8	enzyme
DB17083	Linzagolix	Gonadotropin-releasing hormone receptor	target
DB17083	Linzagolix	Serum albumin	carrier
DB17083	Linzagolix	Cytochrome P450 2C9	enzyme
DB17083	Linzagolix	Cytochrome P450 3A4	enzyme
DB17083	Linzagolix	Solute carrier organic anion transporter family member 1B1	transporter
DB17083	Linzagolix	Solute carrier organic anion transporter family member 1B3	transporter
DB17083	Linzagolix	Solute carrier family 22 member 8	transporter
DB17083	Linzagolix	ATP-binding cassette sub-family G member 2	transporter
DB17083	Linzagolix	Solute carrier family 22 member 6	transporter
DB13055	Oteseconazole	Cytochrome P450 51	target
DB13055	Oteseconazole	ATP-binding cassette sub-family G member 2	transporter

Drug	Drug Name	Phase	Status	Count